• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对生成活化蛋白C能力降低且纤溶酶原激活物抑制剂1缺乏的小鼠流感诱导的凝血和纤维蛋白溶解的影响

Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1.

作者信息

Keller Tymen T, van der Sluijs Koen F, de Kruif Martijn D, Gerdes Victor E A, Meijers Joost C M, Florquin Sandrine, van der Poll Tom, van Gorp Eric C M, Brandjes Dees P M, Büller Harry R, Levi Marcel

机构信息

Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.

出版信息

Circ Res. 2006 Nov 24;99(11):1261-9. doi: 10.1161/01.RES.0000250834.29108.1a. Epub 2006 Oct 26.

DOI:10.1161/01.RES.0000250834.29108.1a
PMID:17068293
Abstract

Influenza infections increase the risk of diseases associated with a prothrombotic state, such as venous thrombosis and atherothrombotic diseases. However, it is unclear whether influenza leads to a prothrombotic state in vivo. To determine whether influenza activates coagulation, we measured coagulation and fibrinolysis in influenza-infected C57BL/6 mice. We found that influenza increased thrombin generation, fibrin deposition, and fibrinolysis. In addition, we used various anti- and prothrombotic models to study pathways involved in the influenza-induced prothrombotic state. A reduced capacity to generate activated protein C in TM(pro/pro) mice increased thrombin generation and fibrinolysis, whereas treatment with heparin decreased thrombin generation in influenza-infected C57Bl/6 mice. Thrombin generation was not changed in hyperfibrinolytic mice, deficient in plasminogen activator inhibitor type-1 (PAI-1(-/-)); however, increased fibrin degradation was seen. Treatment with tranexamic acid reduced fibrinolysis, but thrombin generation was unchanged. We conclude that influenza infection generates thrombin, increased by reduced levels of protein C and decreased by heparin. The fibrinolytic system appears not to be important for thrombin generation. These findings suggest that influenza leads to a prothrombotic state by coagulation activation. Heparin treatment reduces the influenza induced prothrombotic state.

摘要

流感感染会增加与血栓前状态相关疾病的风险,如静脉血栓形成和动脉粥样硬化血栓形成疾病。然而,目前尚不清楚流感在体内是否会导致血栓前状态。为了确定流感是否会激活凝血,我们检测了流感感染的C57BL/6小鼠的凝血和纤溶情况。我们发现流感会增加凝血酶生成、纤维蛋白沉积和纤溶作用。此外,我们使用了各种抗血栓和促血栓模型来研究流感诱导的血栓前状态所涉及的途径。TM(pro/pro)小鼠中生成活化蛋白C的能力降低,会增加凝血酶生成和纤溶作用,而用肝素治疗可降低流感感染的C57BL/6小鼠的凝血酶生成。在纤溶亢进的小鼠中,凝血酶生成没有变化,这些小鼠缺乏纤溶酶原激活物抑制剂1型(PAI-1(-/-));然而,观察到纤维蛋白降解增加。用氨甲环酸治疗可减少纤溶作用,但凝血酶生成没有变化。我们得出结论,流感感染会产生凝血酶,蛋白C水平降低会使其增加,而肝素会使其降低。纤溶系统似乎对凝血酶生成并不重要。这些发现表明,流感通过激活凝血导致血栓前状态。肝素治疗可降低流感诱导的血栓前状态。

相似文献

1
Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1.对生成活化蛋白C能力降低且纤溶酶原激活物抑制剂1缺乏的小鼠流感诱导的凝血和纤维蛋白溶解的影响
Circ Res. 2006 Nov 24;99(11):1261-9. doi: 10.1161/01.RES.0000250834.29108.1a. Epub 2006 Oct 26.
2
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.活化的人蛋白C可预防小鼠体内凝血酶诱导的血栓栓塞。有证据表明,活化蛋白C通过抑制额外的凝血酶生成来减少血管内纤维蛋白的积累。
J Clin Invest. 1998 Feb 1;101(3):667-76. doi: 10.1172/JCI575.
3
Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis.用活化蛋白C进行腹腔灌洗可改变局部凝血和纤维蛋白溶解,并提高多微生物性腹膜炎的生存率。
Crit Care Med. 2006 Nov;34(11):2799-805. doi: 10.1097/01.CCM.0000243795.04284.2A.
4
Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.腹腔内注射重组组织型纤溶酶原激活剂对实验性多微生物腹膜炎凝血、纤溶及炎症反应的影响
Shock. 2007 May;27(5):534-41. doi: 10.1097/01.shk.0000246897.27574.1b.
5
[Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].[凝血酶激活的纤维蛋白溶解抑制剂(TAFI)及其在纤维蛋白溶解调节中的重要性]
Vnitr Lek. 2004 Jan;50(1):36-44.
6
Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.CLI患者凝血和纤溶系统的激活在手术血运重建后并未恢复正常。
Eur J Vasc Endovasc Surg. 2004 Feb;27(2):186-92. doi: 10.1016/j.ejvs.2003.10.015.
7
[The TAFI system. The new role of fibrinolysis].[凝血酶激活的纤溶抑制物系统。纤溶的新作用]
Hamostaseologie. 2007 Sep;27(4):278-81.
8
Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.与普通肝素相比,低分子量肝素对凝血酶依赖性纤溶酶原激活物抑制剂1失活的增强作用较弱。
Thromb Haemost. 2006 Apr;95(4):637-42.
9
Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.2型糖尿病病程延长与凝血酶生成增加、血栓前纤维蛋白凝块表型及纤维蛋白溶解受损有关。
Thromb Haemost. 2014 Apr 1;111(4):685-93. doi: 10.1160/TH13-07-0566. Epub 2013 Dec 5.
10
Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis.血栓调节蛋白:凝血与纤溶的连接因子及动脉血栓形成风险的预测指标。
Ann Med. 2000 Dec;32 Suppl 1:73-7.

引用本文的文献

1
Effect of Oseltamivir Use on Follow-Up Stroke Mortality.使用奥司他韦对后续卒中死亡率的影响。
Pharmaceuticals (Basel). 2025 May 26;18(6):796. doi: 10.3390/ph18060796.
2
High-throughput amino acid-level characterization of the interactions of plasminogen activator inhibitor-1 with variably divergent proteases.纤溶酶原激活物抑制剂-1与可变差异蛋白酶相互作用的高通量氨基酸水平表征
Protein Sci. 2025 Apr;34(4):e70088. doi: 10.1002/pro.70088.
3
TRIM28 regulates the coagulation cascade inhibited by p72 of African swine fever virus.TRIM28 调节由非洲猪瘟病毒 p72 抑制的凝血级联反应。
Vet Res. 2024 Nov 12;55(1):149. doi: 10.1186/s13567-024-01407-6.
4
Viral Infection and Ischemic Stroke: Emerging Trends and Mechanistic Insights.病毒感染与缺血性脑卒中:新兴趋势及作用机制研究进展
J Am Heart Assoc. 2024 Sep 17;13(18):e035892. doi: 10.1161/JAHA.124.035892. Epub 2024 Sep 11.
5
Exposome in ischaemic heart disease: beyond traditional risk factors.外显子组与缺血性心脏病:超越传统危险因素。
Eur Heart J. 2024 Feb 7;45(6):419-438. doi: 10.1093/eurheartj/ehae001.
6
All tangled up: interactions of the fibrinolytic and innate immune systems.错综复杂:纤维蛋白溶解系统与先天免疫系统的相互作用。
Front Med (Lausanne). 2023 Jun 2;10:1212201. doi: 10.3389/fmed.2023.1212201. eCollection 2023.
7
Bivalirudin exerts antiviral activity against respiratory syncytial virus-induced lung infections in neonatal mice.比伐卢定对呼吸道合胞病毒诱导的新生小鼠肺部感染具有抗病毒活性。
Acta Pharm. 2022 Apr 13;72(3):415-425. doi: 10.2478/acph-2022-0022. Print 2022 Sep 1.
8
Nonrespiratory sites of influenza-associated disease: mechanisms and experimental systems for continued study.流感相关疾病的非呼吸部位:持续研究的机制和实验系统。
FEBS J. 2022 Jul;289(14):4038-4060. doi: 10.1111/febs.16363. Epub 2022 Feb 7.
9
Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks.内皮功能障碍与失调的淋巴细胞反应和细胞因子网络共同导致了严重的 COVID-19。
Signal Transduct Target Ther. 2021 Dec 10;6(1):418. doi: 10.1038/s41392-021-00819-6.
10
Comparison of severe and critical COVID-19 patients imported from Russia with and without influenza A infection in Heilongjiang Province: a retrospective study.黑龙江省输入性甲型流感感染与未感染的俄罗斯籍新冠肺炎重症及危重症患者比较:一项回顾性研究
Ann Transl Med. 2021 Sep;9(18):1446. doi: 10.21037/atm-21-3912.